Tranzyme Pharma Appoints Financial and Pharmaceutical Leader Anne M. VanLent to its Board of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Tranzyme Pharma today announced the appointment of Anne M. VanLent to its Board of Directors and to serve on and Chair the Company’s Audit Committee.

MORE ON THIS TOPIC